Trial intelligence / Profile preview

Purple Dan capsule plus entecavir in chronic hepatitis B patients with partial response to entecavir

ChiCTR-IIR-17011845Phase 4Not yet recruiting

Sponsor
Shuguang Hospital
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Shuguang Hospital. Primary endpoints: HBsAg, HBsAb and 3 more. Planned start Mar 2017; status: not yet recruiting.

02

Drugs

entecavir
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on ChiCTR-IIR-17011845.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-17011845.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call